Navigation Links
LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
Date:1/27/2009

LegalView continued to maintain its newsworthy coverage on its Avandia information portal with the recent addition of several new articles detailing the drug's potentially dangerous side effects. The type 2 diabetes drug has been linked to bone fracture, osteoporosis and heart failure among patients.

Denver, CO (PRWEB) January 27, 2009 -- LegalView.info, the most comprehensive legal site available on the Internet, recently updated its Avandia information portal with new articles providing more detail and insight as to the potential Avandia side effects, which have been shown to range from the onset of osteoporosis to bone fractures among women as well as heart failure risks among all patients. Individuals who have recently consumed the drug and may be at risk for developing one of the drug's side effects should consider speaking with not only their medical professional, but an experienced pharmaceutical attorney as well, who can provide information on a potential Avandia lawsuit.

One of the new articles that can be found on the Avandia information portal details a treatment that can work to relieve one of the Avandia side effects. According to a New England Journal of Medicine article, Avandia patients are at an increased risk of developing heart failure; however, researchers may have discovered a technique in which heart failure victims are revived, and, with little side effects. The technique is that of therapeutic hypothermia and it occurs when a victim is cooled in order to avoid the onset of traumatic brain injury, which is often a side effect of a heart failure incident. Although the treatment offers a potential solution to one of the Avandia risks, it may still be necessary for a patient to receive a free legal consultation from an experienced Avandia lawyer.

In addition to providing continually updated news and information on all things Avandia, LegalView also offers details on a variety of other legal topics including the latest on the Fosamax dangers, the peanut butter recall and the cranial implant kit recall.

Fosamax is an osteoporosis drug from makers Merck and Company. Earlier this month, the drug was deemed dangerous by two separate medical publications for its Fosamax side effects, which include jaw bone die off and the potential onset of esophageal cancer. Patients who currently take the drug for bone density loss or osteoporosis should consider seeking medical attention immediately as it may be necessary to stop consumption of the drug.

LegalView has also been providing up-to-the minute news on the peanut butter recall, which has caused nearly 500 U.S. citizens to contract salmonella, seven of which have become fatal, according to multiple news reports. To learn more about the peanut butter recall, individuals are encouraged to obtain information at http://peanut-butter.legalview.info/.
One of the most potentially serious recalls to occur this year is that of Stryker Corporation's Custom Cranial Implant Kit recalls, which were recalled due to issues surrounding the sterility of the kits. If not surgically removed, a patient faces the potential for developing serious side effects as well as an increased risk of death. Patients who have received one of the 322 recalled cranial implant kits should speak with their surgeon immediately to determine the safest way to have the kits removed. Additionally, because of the severity of the side effects and the costs associated with having the kits recalled, it may be advisable for a patient to discuss the development of a cranial implant lawsuit with their attorney, as monetary compensation could be an outcome of such litigation.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.info.

###

Read the full story at http://www.prweb.com/releases/2009/01/prweb1915954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: